Document Detail


Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.
MedLine Citation:
PMID:  18076064     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Knowledge about the burden of Human Papillomavirus (HPV) infections in Sub-Saharan Africa is very limited. We collected cervical samples from 262 women from the general population and 241 tumor samples from women with invasive cervical cancer in Mozambique and tested them for HPV genotyping by the SPF(10)-LiPA(25) PCR system. Among the 195 women without cervical abnormalities by cytology HPV prevalence was 75.9%. In this group of women, the most frequently identified HPV types among HPV-positive women were in descending order of frequency: HPV51 (23.6%), HPV35 (19.6%), HPV18 (14.2%), HPV31 (13.5%) and HPV52 (12.8%). In women with cervical cancer HPV DNA detection was 100%. The type-specific distribution of the most frequent types in descending order of frequency was: HPV16 (47.0%), HPV18 (31.3%), HPV51 (14.8%), HPV52 (14.3%), HPV45 (12.6%), HPV35 (10.4%), HPV33 (4.8%) and HPV31 (2.6%). HPVs 16/18 and HPVs 16/18/31/45 were detected in 71.7% and 80.9% of cervical cancer tissue, respectively. While HPVs 51 and 35 were the two most common types in cytologically normal women in Mozambique, HPVs 16 and 18 remained the two most frequently identified types in cervical cancer. The introduction of an efficacious HPV 16/18 vaccine could potentially prevent the occurrence of 72% of cervical cancer cases and up to 81% of the cases if full cross-protection against HPVs 31 and 45 is assumed.
Authors:
Xavier Castellsagué; Joellen Klaustermeier; Carla Carrilho; Ginesa Albero; Jahit Sacarlal; Wim Quint; Bernhard Kleter; Belen Lloveras; Mamudo Rafik Ismail; Silvia de Sanjosé; F Xavier Bosch; Pedro Alonso; Clara Menéndez
Related Documents :
10632284 - Hpv dna testing of self-collected vaginal samples compared with cytologic screening to ...
15117694 - Prevalence of multiple chemical sensitivities: a population-based study in the southeas...
10444134 - The incidence of phimosis in boys.
19509544 - Cell-mediated immune responses to human papillomavirus 16 e6 and e7 antigens as measure...
6497954 - Alcohol consumption of undergraduates at oxford university.
22891674 - The thyroid hormone receptor α locus and white matter lesions: a role for the clock ge...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  122     ISSN:  1097-0215     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-02-25     Completed Date:  2008-03-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1901-4     Citation Subset:  IM    
Affiliation:
IDIBELL, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain. xcastellsague@iconcologia.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Alphapapillomavirus / genetics,  immunology,  isolation & purification*
Cost of Illness*
DNA, Viral / isolation & purification
Female
Genotype
Human papillomavirus 16 / isolation & purification
Human papillomavirus 18 / isolation & purification
Humans
Middle Aged
Mozambique / epidemiology
Papillomavirus Infections / complications*,  virology
Papillomavirus Vaccines / administration & dosage*
Primary Prevention / methods
Tumor Virus Infections / complications*,  virology
Uterine Cervical Neoplasms / epidemiology*,  genetics,  immunology,  prevention & control*
Chemical
Reg. No./Substance:
0/DNA, Viral; 0/Papillomavirus Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nox1 downstream of 12-lipoxygenase controls cell proliferation but not cell spreading of colon cance...
Next Document:  Mismatch repair expression in testicular cancer predicts recurrence and survival.